Eli Lilly vs. Novo: The Obesity-Drug Battle Is Entering Its Next Round

Reported by Yahoo Finance · Published 21 Sep 2026, 7:30 PM MYT (1 d ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Nearly half of adults under 30 live with their parents. The financial fallout could last for decades. 48 min ago Trump endorses diesel export ban. A decision is coming ‘fast, one way or the other.’ 1 hr ago The bond market is flashing a warning for stocks. These sectors are already wobbling. 1 hr ago Trump bought and sold shares in Musk's SpaceX in July, financial disclosure shows 1 hr ago She was ready to buy her dream condo — but discovered the HOA had just 1% in cash reserves 2 hr ago OpenAI expands GPT-6 lineup with cheaper Sol and Luna models 2 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Eli Lilly vs. Novo: The Obesity-Drug Battle Is Entering Its Next Round

Summary

More in Markets

Nearly half of adults under 30 live with their parents. The financial fallout could last for decades.

Trump endorses diesel export ban. A decision is coming ‘fast, one way or the other.’

The bond market is flashing a warning for stocks. These sectors are already wobbling.

She was ready to buy her dream condo — but discovered the HOA had just 1% in cash reserves

Should you apply for multiple credit cards at once?

Defending against dangerous AI should be a national priority — and we need more AI to do it